Acción 002826 TIBET AIM PHARM. INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Tibet AIM Pharm. Inc.

Acciones

002826

CNE100002C39

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 26/04/2024 		Varia. Cinco días. Varia. 1 de enero.
8,62 CNY +1,29 % Gráfico intradía de Tibet AIM Pharm. Inc. +8,70 % -27,38 %
25/04 Tíbet AIM Pharm. Inc. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
2023 Tibet AIM Pharm. Inc. (SZSE:002826) anuncia una recompra de acciones por valor de 100 millones de CNY. CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Tibet Aim Pharm. Inc. Proposes Final Dividend for 2023
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.
Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.
Tibet AIM Pharm. Inc. announces an Equity Buyback for CNY 100 million worth of its shares.
Tibet AIM Pharm. Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tibet AIM Pharm. Inc. authorizes a Buyback Plan.
Tibet AIM Pharm. Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
Tibet AIM Pharm. Inc. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 07 July 2023
Tibet AIM Pharm. Inc. Approves Cash Dividend for 2022
Tibet Aim Pharm. Inc. Proposes Final Cash Dividend for the Year 2022
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tibet AIM Pharm. Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Tibet Aim Pharm Chairman Resigns; Successor Named
Tibet Aim Pharm Unit to Buy 21% Stake in US Medtech Firm Pier 88 Health for $6 Million
Tibet AIM Pharm. Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
Tibet AIM Pharm. Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
Tibet Aim Pharm. Inc. Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares) for the Year 2021, Payable on 8 July 2022
Tibet AIM Pharm. Inc. Approves 2021 Profit Distribution Plan
Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 002826
  4. Noticias Tibet AIM Pharm. Inc.
  5. Otros idiomas